Robert J Schloesser1, Sophie Orvoen2, Dennisse V Jimenez3, Nicholas F Hardy3, Kristen R Maynard3, Mahima Sukumar3, Husseini K Manji4, Alain M Gardier2, Denis J David2, Keri Martinowich5. 1. University of Maryland School of Medicine, Department of Psychiatry, Baltimore, MD, USA; Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA. 2. Université Paris Sud, INSERM UMR S 1178, Faculté de Pharmacie, Châtenay-Malabry, France. 3. Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA. 4. Global Therapeutic Area Head, Neuroscience, Janssen Research & Development, Titusville, NJ, USA. 5. Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA; Departments of Psychiatry and Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address: keri.martinowich@libd.org.
Abstract
BACKGROUND: Neurogenesis continues throughout life in the hippocampal dentate gyrus. Chronic treatment with monoaminergic antidepressant drugs stimulates hippocampal neurogenesis, and new neurons are required for some antidepressant-like behaviors. Electroconvulsive seizures (ECS), a laboratory model of electroconvulsive therapy (ECT), robustly stimulate hippocampal neurogenesis. HYPOTHESIS: ECS requires newborn neurons to improve behavioral deficits in a mouse neuroendocrine model of depression. METHODS: We utilized immunohistochemistry for doublecortin (DCX), a marker of migrating neuroblasts, to assess the impact of Sham or ECS treatments (1 treatment per day, 7 treatments over 15 days) on hippocampal neurogenesis in animals receiving 6 weeks of either vehicle or chronic corticosterone (CORT) treatment in the drinking water. We conducted tests of anxiety- and depressive-like behavior to investigate the ability of ECS to reverse CORT-induced behavioral deficits. We also determined whether adult neurons are required for the effects of ECS. For these studies we utilized a pharmacogenetic model (hGFAPtk) to conditionally ablate adult born neurons. We then evaluated behavioral indices of depression after Sham or ECS treatments in CORT-treated wild-type animals and CORT-treated animals lacking neurogenesis. RESULTS: ECS is able to rescue CORT-induced behavioral deficits in indices of anxiety- and depressive-like behavior. ECS increases both the number and dendritic complexity of adult-born migrating neuroblasts. The ability of ECS to promote antidepressant-like behavior is blocked in mice lacking adult neurogenesis. CONCLUSION: ECS ameliorates a number of anxiety- and depressive-like behaviors caused by chronic exposure to CORT. ECS requires intact hippocampal neurogenesis for its efficacy in these behavioral indices.
BACKGROUND: Neurogenesis continues throughout life in the hippocampal dentate gyrus. Chronic treatment with monoaminergic antidepressant drugs stimulates hippocampal neurogenesis, and new neurons are required for some antidepressant-like behaviors. Electroconvulsive seizures (ECS), a laboratory model of electroconvulsive therapy (ECT), robustly stimulate hippocampal neurogenesis. HYPOTHESIS: ECS requires newborn neurons to improve behavioral deficits in a mouseneuroendocrine model of depression. METHODS: We utilized immunohistochemistry for doublecortin (DCX), a marker of migrating neuroblasts, to assess the impact of Sham or ECS treatments (1 treatment per day, 7 treatments over 15 days) on hippocampal neurogenesis in animals receiving 6 weeks of either vehicle or chronic corticosterone (CORT) treatment in the drinking water. We conducted tests of anxiety- and depressive-like behavior to investigate the ability of ECS to reverse CORT-induced behavioral deficits. We also determined whether adult neurons are required for the effects of ECS. For these studies we utilized a pharmacogenetic model (hGFAPtk) to conditionally ablate adult born neurons. We then evaluated behavioral indices of depression after Sham or ECS treatments in CORT-treated wild-type animals and CORT-treated animals lacking neurogenesis. RESULTS: ECS is able to rescue CORT-induced behavioral deficits in indices of anxiety- and depressive-like behavior. ECS increases both the number and dendritic complexity of adult-born migrating neuroblasts. The ability of ECS to promote antidepressant-like behavior is blocked in mice lacking adult neurogenesis. CONCLUSION: ECS ameliorates a number of anxiety- and depressive-like behaviors caused by chronic exposure to CORT. ECS requires intact hippocampal neurogenesis for its efficacy in these behavioral indices.
Authors: Anthony D Ramnauth; Kristen R Maynard; Alisha S Kardian; BaDoi N Phan; Madhavi Tippani; Sumita Rajpurohit; John W Hobbs; Stephanie Cerceo Page; Andrew E Jaffe; Keri Martinowich Journal: Brain Stimul Date: 2022-02-17 Impact factor: 8.955
Authors: Priyanka Sinha; Simone L Cree; Allison L Miller; John F Pearson; Martin A Kennedy Journal: Pharmacogenomics J Date: 2021-03-01 Impact factor: 3.550
Authors: H Mohammad; F Marchisella; S Ortega-Martinez; P Hollos; K Eerola; E Komulainen; N Kulesskaya; E Freemantle; V Fagerholm; E Savontaus; H Rauvala; B D Peterson; H van Praag; E T Coffey Journal: Mol Psychiatry Date: 2016-11-15 Impact factor: 15.992
Authors: Andrew D Chang; Punit V Vaidya; Edward P Retzbach; Sunho J Chung; Urian Kim; Kathryn Baselice; Kristen Maynard; Alec Stepanian; Melissa Staley; Lan Xiao; Ashley Blouin; Sungho Han; JongAh Lee; Paul F Worley; Kellie L Tamashiro; Barbara L Hempstead; Keri Martinowich; Mary Ann Wilson; Jay M Baraban; Irving M Reti Journal: Neuropsychopharmacology Date: 2017-10-20 Impact factor: 8.294
Authors: M Polyakova; M L Schroeter; B M Elzinga; S Holiga; P Schoenknecht; E R de Kloet; M L Molendijk Journal: PLoS One Date: 2015-11-03 Impact factor: 3.240